Literature DB >> 35175945

COVID-19 Vaccine-Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT.

Soo Jin Lee1, Dong Won Park2, Jang Won Sohn2, Ho Joo Yoon2, Sang-Heon Kim2.   

Abstract

ABSTRACT: Of the various adverse reactions to COVID-19 vaccines, fever is a common systemic symptom that often resolves spontaneously without treatment. However, rare vaccine-induced conditions that present with fever and systemic inflammation have been reported. In this case, a 65-year-old man with BNT162b2 mRNA COVID-19 vaccination underwent 18F-FDG PET/CT to evaluate prolonged fever and elevated serum C-reactive protein. PET/CT showed hypermetabolic infiltration in the pericardium and peritoneum suggesting immune-mediated pericarditis and peritonitis. After administration of high-dose corticosteroids, the patient's symptom resolved. This case suggests that multisystem inflammatory syndrome and polyserositis can be induced by the COVID-19 vaccine.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35175945      PMCID: PMC8983611          DOI: 10.1097/RLU.0000000000004094

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


A 65-year-old man with 5 days of fever. The fever developed 1 day after vaccination with the first dose of the BNT162b2 mRNA COVID-19 vaccine and persisted despite intermittent use of antipyretics. He felt mild shortness of breath when experiencing febrile sensations. On admission, his vital signs showed a temperature of 39.4°C, blood pressure of 119/70 mm Hg, pulse rate of 79 beats/min, respiratory rate of 20 breaths/min, and oxygen saturation of 96%. Polymerase chain reaction tests for COVID-19 via a nasopharyngeal swab were negative three times. Laboratory results documented mild leukocytosis (11,700 cells/μL) with an absolute lymphocyte count of 670 cells/μL. Serum C-reactive protein (27.7 mg/dL), erythrocyte sedimentation rate (58 mm/h), ferritin (899 ng/mL), d-dimer (4.45 mg/L), lactate dehydrogenase (337 U/L), aspartate aminotransferase (149 U/L), and alanine aminotransferase (302 U/L) concentrations were all markedly elevated, suggesting severe inflammation and acute liver injury. 18F-FDG PET/CT was then performed for further evaluation. The image of MIP (A, arrows) revealed suspicious mild hypermetabolic activity in mediastinum and abdominal cavity. On axial PET/CT and CT images, mild diffuse hypermetabolic activity is localized in the mediastinal line (B and C) and pericardial thickening with fat infiltration (D and E, white arrows). CT image shows bilateral pleural effusion (C, yellow arrows). These findings were indicative of mediastinitis, pericarditis, and pleuritis. Abdominal PET/CT and CT images (F and G) demonstrated hypermetabolic activity along perinephric (arrow heads) and peritoneal thickening (arrows), suggestive of peritonitis. Consultation with the infection specialist and rheumatology specialist revealed little evidence of infectious disease or connective tissue diseases, even after vigorous examinations, laboratory, and imaging tests. Based on these findings, the patient was diagnosed with COVID-19 vaccine–induced multisystem inflammatory syndrome (MIS) with polyserositis. After the administration of high-dose oral corticosteroids, the patient's fever, pleural effusions, and biomarkers of systemic inflammation resolved gradually without sequelae. The patient did not receive any kind of COVID-19 vaccine after that. Some patients with COVID-19 show systemic hyperinflammation by increased cytokine production, the so-called cytokine storm.[1] Multisystem inflammatory syndrome associated with COVID-19 has been observed both in children and in adults.[2,3] Mimicking these conditions, a few cases that manifest with fever and multisystem inflammatory responses after COVID-19 vaccinations have been previously reported.[4-7] Our patient showed fever, laboratory evidence of severe systemic inflammation, acute liver injury, imaging evidence of mediastinitis, pleuritis, pericarditis, and peritonitis, without evidence of severe respiratory illness. These findings met the criteria for MIS in adults, except for negative test results for SARS-CoV-2 infection.[8] Interestingly, our patient had mild bilateral pleural effusions, whereas there was no evidence of pneumonia, pulmonary embolism, or heart failure. Analysis of the pleural effusion was not performed because the pleural effusion was small. The PET/CT findings altogether illustrated multisystem inflammation in multiple serosae including the pleural, pericardium, and peritoneum. Although this case had several features suggesting adult-onset Still disease, it did not meet the diagnostic criteria.[9] FDG PET/CT is helpful in evaluating these possible systemic manifestations of COVID-19 vaccine adverse reactions, especially in patients with persistent fever after vaccination.
  9 in total

1.  Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT.

Authors:  Ayah Adel Nawwar; Julie Searle; Iain Douglas Lyburn
Journal:  Clin Nucl Med       Date:  2022-01-01       Impact factor: 7.794

2.  Characteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection.

Authors:  Giovanni E Davogustto; Daniel E Clark; Edward Hardison; Ahmad H Yanis; Brandon D Lowery; Natasha B Halasa; Quinn S Wells
Journal:  JAMA Netw Open       Date:  2021-05-03

3.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

Authors:  Leora R Feldstein; Erica B Rose; Steven M Horwitz; Jennifer P Collins; Margaret M Newhams; Mary Beth F Son; Jane W Newburger; Lawrence C Kleinman; Sabrina M Heidemann; Amarilis A Martin; Aalok R Singh; Simon Li; Keiko M Tarquinio; Preeti Jaggi; Matthew E Oster; Sheemon P Zackai; Jennifer Gillen; Adam J Ratner; Rowan F Walsh; Julie C Fitzgerald; Michael A Keenaghan; Hussam Alharash; Sule Doymaz; Katharine N Clouser; John S Giuliano; Anjali Gupta; Robert M Parker; Aline B Maddux; Vinod Havalad; Stacy Ramsingh; Hulya Bukulmez; Tamara T Bradford; Lincoln S Smith; Mark W Tenforde; Christopher L Carroll; Becky J Riggs; Shira J Gertz; Ariel Daube; Amanda Lansell; Alvaro Coronado Munoz; Charlotte V Hobbs; Kimberly L Marohn; Natasha B Halasa; Manish M Patel; Adrienne G Randolph
Journal:  N Engl J Med       Date:  2020-06-29       Impact factor: 91.245

Review 4.  Mechanisms, biomarkers and targets for adult-onset Still's disease.

Authors:  Eugen Feist; Stéphane Mitrovic; Bruno Fautrel
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

5.  Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020.

Authors:  Sapna Bamrah Morris; Noah G Schwartz; Pragna Patel; Lilian Abbo; Laura Beauchamps; Shuba Balan; Ellen H Lee; Rachel Paneth-Pollak; Anita Geevarughese; Maura K Lash; Marie S Dorsinville; Vennus Ballen; Daniel P Eiras; Christopher Newton-Cheh; Emer Smith; Sara Robinson; Patricia Stogsdill; Sarah Lim; Sharon E Fox; Gillian Richardson; Julie Hand; Nora T Oliver; Aaron Kofman; Bobbi Bryant; Zachary Ende; Deblina Datta; Ermias Belay; Shana Godfred-Cato
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-10-09       Impact factor: 17.586

6.  18F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.

Authors:  Julie Steinberg; Alex Thomas; Amir Iravani
Journal:  Lancet       Date:  2021-03-08       Impact factor: 79.321

7.  Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination.

Authors:  Ahmad Kanaan Uwaydah; Nidal M M Hassan; Mousa Suhail Abu Ghoush; Karim Mohamed Mohamed Shahin
Journal:  BMJ Case Rep       Date:  2021-04-21

8.  Adult-onset Still's disease following COVID-19 vaccination.

Authors:  Flavia Leone; Pier Giacomo Cerasuolo; Silvia Laura Bosello; Lucrezia Verardi; Enrica Fiori; Fabrizio Cocciolillo; Biagio Merlino; Angelo Zoli; Maria Antonietta D'Agostino
Journal:  Lancet Rheumatol       Date:  2021-07-22

9.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.